Reconstituted Lipid Nanoparticles from Cells/Tissues for Drug Delivery in Cancer
Molecular Pharmaceutics · 2023
DOI: 10.1021/acs.molpharmaceut.2c01033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2023. Verfasst von Cheng Wang. Beteiligte Einrichtung: School of Pharmacy, Changzhou University, Changzhou 213164, Jiangsu, P. R. China. Hauptthemen laut MEDLINE: Nanoparticles, Curcumin, Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Jiangsu Province Postdoctoral Science Foundation, Jiangsu Provincial Department of Education, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Changzhou University, Changzhou 213164, Jiangsu, P. R. China.
ORCID-Profile: Cheng Wang
Förderung
- Jiangsu Province Postdoctoral Science Foundation
- Jiangsu Provincial Department of Education
- China Postdoctoral Science Foundation
- Natural Science Foundation of Jiangsu Province
- Changzhou Science and Technology Bureau
- State Key Laboratory of Radiation Medicine and Protection
Zitieren
APA
Wang, C. (2023). Reconstituted Lipid Nanoparticles from Cells/Tissues for Drug Delivery in Cancer. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.2c01033
Vancouver
Wang C. Reconstituted Lipid Nanoparticles from Cells/Tissues for Drug Delivery in Cancer. Molecular Pharmaceutics. 2023. doi:10.1021/acs.molpharmaceut.2c01033
BibTeX
@article{Wang2023,
author = {Wang, Cheng},
title = {Reconstituted Lipid Nanoparticles from Cells/Tissues for Drug Delivery in Cancer},
journal = {Molecular Pharmaceutics},
year = {2023},
doi = {10.1021/acs.molpharmaceut.2c01033}
}
EUVIMED